Servier Research Deals Suggest Business-As-Usual For Scandal-Ridden Firm

Still reeling from the Mediator scandal, Servier's two latest cancer research deals suggest the French company is trying to move forward.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet